{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:53:04Z","timestamp":1791262384402,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.hpb.2026.09.002","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:26:47Z","timestamp":1789831607000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of metabolic dysfunction-associated steatotic liver disease with colorectal cancer incidence and surgical outcomes"],"prefix":"10.1016","author":[{"given":"Abdulaziz","family":"Elemosho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selamawit","family":"Woldesenbet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3965-4505","authenticated-orcid":false,"given":"Arshum","family":"Mirzaeifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2899-4030","authenticated-orcid":false,"given":"Kizuki","family":"Yuza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4490-4453","authenticated-orcid":false,"given":"Meher","family":"Angez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8377-0263","authenticated-orcid":false,"given":"Odysseas P.","family":"Chatzipanagiotou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3688-5077","authenticated-orcid":false,"given":"Charalampos M.","family":"Charalampous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areesh","family":"Mevawalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6455-3005","authenticated-orcid":false,"given":"Qaidar","family":"Alizai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rida","family":"Ejaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Arena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4715-5937","authenticated-orcid":false,"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2026.09.002_bib1","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2026.09.002_bib2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of metabolic dysfunction-associated steatotic liver disease","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol Metabol"},{"issue":"Suppl","key":"10.1016\/j.hpb.2026.09.002_bib3","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.hpb.2026.09.002_bib4","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra2412865","article-title":"Metabolic dysfunction-associated steatotic liver disease","volume":"393","author":"Targher","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hpb.2026.09.002_bib5","doi-asserted-by":"crossref","first-page":"156004","DOI":"10.1016\/j.metabol.2024.156004","article-title":"Metabolic dysfunction-associated steatotic liver disease and its link to cancer","volume":"160","author":"Kalligeros","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.hpb.2026.09.002_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156014","article-title":"Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers","volume":"160","author":"Mantovani","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.hpb.2026.09.002_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14276","article-title":"Association of MASLD with the risk of extrahepatic cancers: a systematic review and meta-analysis of 18 cohort studies","volume":"54","author":"Zhou","year":"2024","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.hpb.2026.09.002_bib8","doi-asserted-by":"crossref","first-page":"1368965","DOI":"10.3389\/fonc.2024.1368965","article-title":"Association between metabolic dysfunction-associated steatotic liver disease and risk of colorectal cancer or colorectal adenoma: an updated meta-analysis of cohort studies","volume":"14","author":"Zhao","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.hpb.2026.09.002_bib9","article-title":"Association between nonalcoholic fatty liver disease and colorectal cancer: a population-based study","volume":"102","author":"Wu","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.hpb.2026.09.002_bib10","article-title":"Colorectal cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.hpb.2026.09.002_bib11","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1200\/JCO.22.01740","article-title":"Increased risk of young-onset digestive tract cancers among young adults age 20\u201339 years with nonalcoholic fatty liver disease: a nationwide cohort study","volume":"41","author":"Park","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hpb.2026.09.002_bib12","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.cgh.2025.02.020","article-title":"Association between nonalcoholic fatty liver disease and risk of early-onset colorectal cancer","volume":"23","author":"Kim","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2026.09.002_bib13","article-title":"The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: national population-based cohort study","volume":"15","author":"Lee","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.hpb.2026.09.002_bib14","doi-asserted-by":"crossref","first-page":"1037211","DOI":"10.3389\/fendo.2022.1037211","article-title":"Nonalcoholic fatty liver disease is specifically related to the risk of hepatocellular cancer but not extrahepatic malignancies","volume":"13","author":"Albhaisi","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.hpb.2026.09.002_bib15","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3174\/ajnr.A4696","article-title":"ICD-10: history and context","volume":"37","author":"Hirsch","year":"2016","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.hpb.2026.09.002_bib16","unstructured":"National Cancer Institute Surveillance, Epidemiology, and End Results Program. Colorectal cancer stat Facts: age-adjusted incidence 37.6 per 100,000 persons per year, 2019-2023."},{"key":"10.1016\/j.hpb.2026.09.002_bib17","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.cgh.2024.12.018","article-title":"Colorectal cancer incidence in steatotic liver disease (MASLD, MetALD, and ALD)","volume":"23","author":"Kimura","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2026.09.002_bib18","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00384-013-1656-2","article-title":"Hepatic steatosis is associated with lower incidence of liver metastasis from colorectal cancer","volume":"28","author":"Murono","year":"2013","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.hpb.2026.09.002_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108618","article-title":"Patients with chronically diseased livers have lower incidence of colorectal liver metastases: a meta-analysis","volume":"9","author":"Cai","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.hpb.2026.09.002_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41420-023-01770-x","article-title":"Non-alcoholic fatty liver disease promotes liver metastasis of colorectal cancer via fatty acid synthase-dependent EGFR palmitoylation","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.hpb.2026.09.002_bib21","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.cmet.2023.04.013","article-title":"Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment","volume":"35","author":"Wang","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.hpb.2026.09.002_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2024.04.008","article-title":"Concomitant NAFLD facilitates liver metastases and PD-1-Refractory by recruiting MDSCs via CXCL5\/CXCR2 in colorectal cancer","volume":"18","author":"Yang","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2026.09.002_bib23","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.62347\/JHMS4303","article-title":"Hepatic steatosis predicts metachronous liver metastasis in colorectal cancer patients: a nested case-control study and systematic review","volume":"14","author":"Dai","year":"2024","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.hpb.2026.09.002_bib24","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/bjs.9057","article-title":"Fatty liver disease as a predictor of local recurrence following resection of colorectal liver metastases","volume":"100","author":"Hamady","year":"2013","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2026.09.002_bib25","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1007\/s00268-023-07069-3","article-title":"Colorectal surgery in patients with liver cirrhosis: a systematic review","volume":"47","author":"Ng","year":"2023","journal-title":"World J Surg"},{"key":"10.1016\/j.hpb.2026.09.002_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/curroncol33010029","article-title":"Postoperative survival analysis of elective colorectal cancer surgery with liver cirrhosis: a propensity-matched study","volume":"33","author":"Tsai","year":"2026","journal-title":"Curr Oncol"},{"key":"10.1016\/j.hpb.2026.09.002_bib27","doi-asserted-by":"crossref","first-page":"1538073","DOI":"10.3389\/fonc.2025.1538073","article-title":"Impact of visceral obesity on postoperative outcomes in colorectal cancer: a systematic review and meta-analysis","volume":"15","author":"Wang","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.hpb.2026.09.002_bib28","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1097\/MS9.0000000000003059","article-title":"Preoperative body composition metrics as predictors for outcomes in colorectal cancer surgeries, A systematic review","volume":"87","author":"Salabat","year":"2025","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.hpb.2026.09.002_bib29","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/jama.2021.6238","article-title":"Screening for colorectal cancer: US Preventive Services Task Force recommendation statement","volume":"325","author":"Preventive Services Task Force","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.hpb.2026.09.002_bib30","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1055\/s-0041-1731004","article-title":"The Cosmos Collaborative: A Vendor-Facilitated Electronic Health Record Data Aggregation Platform","volume":"5","author":"Tarabichi","year":"2021","journal-title":"ACI Open"},{"key":"10.1016\/j.hpb.2026.09.002_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jamia\/ocae253","article-title":"Application of a digital quality measure for cancer diagnosis in Epic Cosmos","volume":"32","author":"Zimolzak","year":"2025","journal-title":"J Am Med Inform Assoc"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X26027498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X26027498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:19:33Z","timestamp":1791260373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X26027498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"alternative-id":["S1365182X26027498"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2026.09.002","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of metabolic dysfunction-associated steatotic liver disease with colorectal cancer incidence and surgical outcomes","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2026.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Hepato-Pancreato-Biliary Association Inc.","name":"copyright","label":"Copyright"}]}}